🇺🇸 FDA
Patent

US 7300919

Pulmonary delivery of active fragments of parathyroid hormone

granted A61KA61K38/29A61K9/0073

Quick answer

US patent 7300919 (Pulmonary delivery of active fragments of parathyroid hormone) held by Nektar Therapeutics expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/29, A61K9/0073, A61K9/0075, A61K9/0078